Table 2 HCT, Vit.B12 and Folate and cognitive capacity (number of people and prevalence proportions)
MMSE > 24 | MMSE ≤ 24 | Total | |
|---|---|---|---|
N (%) | N (%) | N (%) | |
HCT | |||
Normal* | |||
Male | 137 (65.6) | 72 (34.4) | 209 (100) |
Female | 139 (59.9) | 93 (40.1) | 232 (100) |
Total | 276 (62.6) | 165 (37.4) | 441 (100) |
Abnormal | |||
Male | 16 (44.4) | 20 (55.6) | 36 (100) |
Female | 31 (52.5) | 28 (47.5) | 59 (100) |
Total | 47 (49.5) | 48 (50.5) | 95 (100) |
Vit.B12 | |||
Normal | |||
Male | 144 (65.2) | 77 (34.8) | 221 (100) |
Female | 154 (59.5) | 105 (40.5) | 259 (100) |
Total | 298 (62.1) | 182 (37.9) | 480 (100) |
Abnormal | |||
Male | 9 (37.5) | 15 (62.5) | 24 (100) |
Female | 16 (50) | 16 (50) | 32 (100) |
Total | 25 (44.6) | 31 (55.4) | 56 (100) |
Folate | |||
Normal | |||
Male | 149 (62.3) | 90 (37.7) | 239 (100) |
Female | 166 (58.9) | 116 (41.1) | 282 (100) |
Total | 315 (60.3) | 206 (39.5) | 521 (100) |
Abnormal | |||
Male | 4 (66.7) | 2 (33.3) | 6 (100) |
Female | 4 (44.4) | 5 (55.6) | 9 (100) |
Total | 8 (53.3) | 7 (46.7) | 15 (100) |